Publicaciones (23) Publicaciones de JOSÉ MANUEL JIMÉNEZ LÓPEZ

2017

  1. Alkylphospholipids: An update on molecular mechanisms and clinical relevance

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1859, Núm. 9, pp. 1657-1667

2016

  1. Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism

    Experimental Cell Research, Vol. 340, Núm. 1, pp. 81-90

2015

  1. Cholesterol homeostasis and autophagic flux in perifosine-treated human hepatoblastoma HepG2 and glioblastoma U-87 MG cell lines

    Biochemical Pharmacology, Vol. 96, Núm. 1, pp. 10-19

  2. New strategies for teaching advanced biochemical techniques to English learners

    Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XI FECIES

2014

  1. Antitumoral alkylphospholipids alter cell lipid metabolism

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 14, Núm. 4, pp. 545-558

2013

  1. Lipid Efflux Mediated by Alkylphospholipids in HepG2 Cells

    Cell Biochemistry and Biophysics, Vol. 66, Núm. 3, pp. 737-746

2011

  1. Antitumoral alkylphospholipids induce cholesterol efflux from the plasma membrane in HepG2 cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 336, Núm. 3, pp. 866-873

2010

  1. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids

    Lipids in Health and Disease, Vol. 9

  2. Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues

    British Journal of Pharmacology, Vol. 160, Núm. 2, pp. 355-366

2009

  1. Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells

    International Journal of Biochemistry and Cell Biology, Vol. 41, Núm. 6, pp. 1296-1303

2008

  1. Hexadecylphosphocholine interferes with the intracellular transport of cholesterol in HepG2 cells

    FEBS Journal, Vol. 275, Núm. 8, pp. 1675-1686

  2. Synergistic toxicity induced by prolonged glutathione depletion and inhibition of nuclear factor-kappaB signaling in liver cells

    Toxicology in Vitro, Vol. 22, Núm. 1, pp. 106-115

2007

  1. Effects of ethanol on the remodeling of neutral lipids and phospholipids in brain mitochondria and microsomes

    Neurochemistry International, Vol. 50, Núm. 6, pp. 858-865

  2. Quantitative genetic analysis of flowering time in tomato

    Genome, Vol. 50, Núm. 3, pp. 303-315

2006

  1. Ethanol specifically alters the synthesis, acylation and transbilayer movement of aminophospholipids in rat-liver microsomes

    Life Sciences, Vol. 78, Núm. 24, pp. 2781-2786

  2. Hexadecylphosphocholine disrupts cholesterol homeostasis and induces the accumulation of free cholesterol in HepG2 tumour cells

    Biochemical Pharmacology, Vol. 71, Núm. 8, pp. 1114-1121

2005

  1. CYP2E1-dependent oxidative stress and toxicity: Role in ethanol-induced liver injury

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Núm. 4, pp. 671-685

  2. Protein kinase C signaling as a survival pathway against CYP2E1-derived oxidative stress and toxicity in HepG2 cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 3, pp. 998-1006

2004

  1. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity

    Free Radical Biology and Medicine, Vol. 36, Núm. 3, pp. 359-370

  2. Hexadecylphosphocholine inhibits phosphatidylcholine synthesis via both the methylation of phosphatidylethanolamine and CDP-choline pathways in HepG2 cells

    International Journal of Biochemistry and Cell Biology, Vol. 36, Núm. 1, pp. 153-161